Hyperpigmentation as a rare side effect of adalimumab

Int J Dermatol. 2021 Mar;60(3):e105-e106. doi: 10.1111/ijd.15268. Epub 2020 Oct 27.

Authors

Francisco Gil¹, Isabel Andrade², João Aranha¹

Affiliations

¹ Dermatology Department, Hospital de Santarém EPE, Santarém, Portugal.
² Pathological Anatomy Department, Hospital de Santarém EPE, Santarém, Portugal.

PMID: 33107034
DOI: 10.1111/ijd.15268

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / adverse effects
Antibodies, Monoclonal, Humanized
Humans
Hyperpigmentation* / chemically induced

Substances

Antibodies, Monoclonal, Humanized
Adalimumab